A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

NCT00525330 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: KRP-104 QD Drug: Placebo Drug: Metformin
DRUG: Placebo Drug: Metformin
DRUG: KRP-104 BID Drug: Placebo Drug: Metformin

Sponsor

ActivX Biosciences, Inc.

Collaborators

[object Object]